Concerning the Allowance for Terminally Ill Patients to Have access to Investigational Products that Have Not Been Approved by the Federal Food and Drug Administration that Other Patients Have Access to When They Participate in Clinical Trials.

Authors

Colorado General Assembly

Files

Publication Date

2014

Chapter

220

Session Type

Regular

Session Number

2

Document Type

Act

Start Page

823

Recommended Citation

Colorado General Assembly, "Concerning the Allowance for Terminally Ill Patients to Have access to Investigational Products that Have Not Been Approved by the Federal Food and Drug Administration that Other Patients Have Access to When They Participate in Clinical Trials." (2014). Session Laws 2001-Present. 6143.
https://scholar.law.colorado.edu/session-laws-2001-2050/6143